Abstract
Although genetic testing for ASD is the standard of clinical care in the USA, the use of advanced genetic tests in children with ASD is controversial. The aim of this study was to access parental genetic knowledge, attitudes, and intention regarding advanced genetic testing for autism. Our final dataset consisted of 207 valid responses. Our final sample included 207 parents of children with ASD and most are mothers of children (88.9%). The average age of our participants is 37.8 years old. The majority of our participants are Caucasian (73.4%), followed by African Americans (13.5%), Hispanics (7.7%), Native Americans/American Indians (2.4%), and Asians (2.9%). A large number of parents (85%) reported were not aware of the advanced level of genetic testing, such as chromosomal microarray analysis (CMA) and whole-genome sequencing (WES). Most parents (84%) reported that they would take their children to undergo genetic testing. This study was a cross-sectional study using a convenience sampling technique through a variety of community outlets in Eastern North Carolina between January 2016 and May 2016. And the most significant predicators of parents’ genetic knowledge were education attainment (P < 0.05) and income (P < 0.05). Also, parents with more positive attitudes about genetic testing had higher intention to take their children to get tested than those with less positive attitudes. Our findings reflect the immediate need to educate parents with lower education/income levels about genetic testing for ASD. Educating parents about these genetic tests can help parents make more informed decisions associated with testing their children with ASD in future studies.
Similar content being viewed by others
References
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211.
Anagnostou, E., Zwaigenbaum, L., Szatmari, P., Fombonne, E., Fernandez, B. A., Woodbrury-Smith, M., et al. (2014). Autism spectrum disorder: advances in evidence-based practice. CMAJ: Canadian Medical Association Journal = Journal De l’Association Medicale Canadienne, 186(7), 509–519.
Anwar, A., Abruzzo, P. M., Pasha, S., Rajpoot, K., Bolotta, A., Ghezzo, A., et al. (2018). Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism—a source of biomarkers for clinical diagnosis. Mol Autism, 9, 3. https://doi.org/10.1186/s13229-017-0183-3.
Bailey, D. B., Bishop, E., Raspa, M., & Skinner, D. (2012). Caregiver opinions about fragile X population screening. Genetics in Medicine, 14(1), 115–121.
Bauer, S. C., & Msall, M. E. (2011). Genetic testing for autism spectrum disorders. Developmental Disabilities Research Reviews, 17(1), 3–8.
Becker, M. H. (1974). The health belief model and personal health behavior. Health Education Monographs, 2, 324–508.
Bunn, J. Y., Bosompra, K., Ashikaga, T., Flynn, B. S., & Worden, J. K. (2002). Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study. Preventive Medicine, 34, 567–577.
Carter, M., & Scherer, S. (2013). Autism spectrum disorder in the genetics clinic: a review. Clinical Genetics, 83(5), 399–407.
Centers for Disease Control and Prevention (CDC), & Developmental Disabilities Monitoring Network Surveillance 2014 Year Principal Investigators. (2018). Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, united states, 2014. Morbidity and Mortality Weekly Report. Surveillance Summaries., 67(6), 1–23.
Centers for Disease Control and Prevention (CDC), & Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators. (2014). Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, united states, 2010. Morbidity and Mortality Weekly Report. Surveillance Summaries, 63(2), 1–21.
Chen, L. S., Xu, L., Huang, T. Y., & Dhar, S. U. (2013). Autism genetic testing: a qualitative study of awareness, attitudes, and experiences among parents of children with autism spectrum disorders. Genetics in Medicine, 15(4), 274.
Chen, L. S., Xu, L., Dhar, S. U., Li, M., & Jung, E. (2015). Autism spectrum disorders: a qualitative study of attitudes toward prenatal genetic testing and termination decisions of affected pregnancies. Clinical Genetics, 88(2), 122–128.
Clark, S., Bluman, L. G., Borstelmann, N., Regan, K., et al. (2000). Patient motivation, satisfaction, and co** in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling, 9(3), 219–235.
Cyr, A., Dunnagan, T. A., & Haynes, G. (2010). Efficacy of the health belief model for predicting intention to pursue genetic testing for colorectal cancer. Journal of Genetic Counseling, 19(2), 174–186.
Dodson, D. S., Goldenberg, A. J., Davis, M. M., Singer, D. C., & Tarini, B. A. (2015). Parent and public interest in whole-genome sequencing. Public Health Genomics, 18(3), 151–159.
Fitzgerald-Butt, S. M., Klima, J., Kelleher, K., Chisolm, D., & McBride, K. L. (2014). Genetic knowledge and attitudes of parents of children with congenital heart defects. American Journal of Medical Genetics Part A, 164(12), 3069–3075.
Genetic testing for cystic fibrosis. (1999). National institutes of health consensus development conference statement on genetic testing for cystic fibrosis. Archives of Internal Medicine, 159(14), 1529–1539.
Gooding, H. C., Organista, K., Burack, J., & Biesecker, B. B. (2006). Genetic susceptibility testing from a stress and co** perspective. Social Science & Medicine, 62(8), 1880–1890.
Hartman, K. A. (2002). Health belief model and it’s application to mammography screening in a K-12 school district employee wellness program. Bozeman: Montana State University.
Janssens, S., Chokoshvilli, D., Binst, C., Mahieu, I., Henneman, L., De, P. A., et al. (2016). Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues. European Journal of Human Genetics, 24(4), 506.
Jeon, K. C., Chen, L. S., & Goodson, P. (2012). Abortion decision-making after prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature. Genetics in Medicine, 14(1), 27–38.
Jiang, Y., Wang, Y., **u, X., Choy, K. W., Pursley, A. N., & Cheung, S. W. (2014). Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Critical Reviews in Clinical Laboratory Sciences, 51(5), 249–262.
Johannessen, J., Nærland, T., Hope, S., Torske, T., Hoyland, A. L., Strohmaler, J., et al. (2017). Parents’ attitudes toward clinical genetic testing for autism spectrum disorder—data from a Norwegian sample. International Journal of Molecular Sciences, 18(5), 1078.
Jonassaint, C. R., Santos, E. R., Glover, C. M., Payne, P. W., Fasaye, G. A., Oji-Njideka, N., et al. (2010). Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry. Human Genetics, 128(3), 249–260.
Jones, D. L., & Clayton, E. W. (2012). The role of distress in uptake and response to predisposition genetic testing: The BMPR2 experience. Genetic Testing and Molecular Biomarkers, 16(3), 23–209.
Jordan, B. R., & Tsai, D. F. C. (2010). Whole-genome association studies for multigenic diseases: Ethical dilemmas arising from commercialization—the case of genetic testing for autism. Journal of Medical Ethics, 36(7), 440–444.
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and co**. New York: Springer Publishing Co.
Lerman, C., & Croyle, R. T. (1996). Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology (Huntington), 10(2), 191–195, 199; discussion, 200–202.
Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65(3), 414–420.
Leventhal, H. L. E., & Cameron, L. (2001). Handbook of health psychology. Mahwah: Lawrence Erlbaum Associates.
Lipstein, E. A., Nabi, E., Perrin, J. M., Luff, D., Browning, M. F., & Kuhlthau, K. A. (2010). Parents’ decision-making in newborn screening: opinions, choices, and information needs. Pediatrics, 126(4), 696–704.
Marchant, G. E., & Robert, J. S. (2009). Genetic testing for autism predisposition: ethical, legal and social challenges. Houston Journal of Health Law & Policy, 9, 203–235.
Maya, I., Davidov, B., Gershovitz, L., Zalzstein, Y., Taub, E., Cop**er, J., et al. (2010). Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenatal Diagnosis, 30(12–13), 1131–1137.
Miles, J. H. (2011). Autism spectrum disorders—a genetics review. Genetics in Medicine, 13(4), 278–294.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The America Journal of Human Genetics, 86(5), 749–764 Uppsala universitet.
Narcisa, V., Discenza, M., Vaccari, E., Rosen-Sheidley, B., Hardan, A. Y., & Couchon, E. (2012). Parental interest in a genetic risk assessment test for autism spectrum disorders. Clinical Pediatrics, 52(2), 139–146.
Ozonoff, S., Young, G. S., Carter, A., Messinger, D., Yirmiya, N., Zwaigenbaum, L., et al. (2011). Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics, 128(3), e488.
Rapin, I., Trentacoste, S. V., & Muhle, R. (2004). The genetics of autism. Pediatrics, 113(5), 1389.
Reiff, M., Bernhardt, B. A., Mulchandani, S., Soucier, D., Cornell, D., Pyeritz, R. E., et al. (2012). “what does it mean?”: uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14(2), 250.
Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., et al. (2015). Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 45(10), 3262–3275.
Schaefer, G. B., Mendelsohn, N. J., Practice, P., & Committee, G. (2013). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in Medicine, 15(5), 399.
Selkirk, C. G., McCarthy Veach, P., Lian, F., Schimmenti, L., & LeRoy, B. S. (2009). Parents’ perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. Journal of Genetic Counseling, 18(5), 507.
Skafidas, E., Testa, R., Zantomio, D., Chana, G., Everall, I. P., & Pantelis, C. (2012). Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Molecular Psychiatry, 19, 504–510.
Skinner, D., Sparkman, K. L., Bailey, J., & Donald, B. (2003). Screening for fragile X syndrome: parent attitudes and perspectives. Genetics in Medicine, 5(5), 378–384.
Sterling, R., Henderson, G. E., & Corbie-Smith, G. (2006). Public willingness to participate in and public opinions about genetic variation research: a review of the literature. American Journal of Public Health, 96(11), 1971–1978.
Szego, M. J., & Zawati, M. H. (2016). Whole genome sequencing as a genetic test for autism spectrum disorder: from bench to bedside and then back again. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De l’Académie Canadienne De Psychiatrie De l’Enfant Et De l’Adolescent, 25(2), 116.
Tammimies, K., Marshall, C. R., Walker, S., Kaur, G., Thiruvahindrapuram, B., Lionel, A. C., et al. (2015). Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA, 314(9), 895–903.
Tercyak, K. P., Hensley Alford, S., Emmons, K. M., Lipkus, I. M., Wilfond, B. S., & McBride, C. M. (2011). Parents’ attitudes toward pediatric genetic testing for common disease risk. Pediatrics, 127(5), e1288–e1295.
Trottier, M., Roberts, W., Drmic, I., Scherer, S. W., et al. (2013). Parents’ perspectives on participating in genetic research in autism. Journal of Autism and Developmental Disorders, 43(3), 556–568.
Vande Wydeven, K., Kwan, A., Hardan, A. Y., & Bernstein, J. A. (2012). Underutilization of genetics services for autism: the importance of parental awareness and provider recommendation. Journal of Genetic Counseling, 21(6), 803–813.
Xu, L., Carpenter-Abey, T., Abey, V. G., & Lu, W. (2015). An integrated model of emotions, attitudes and intention associated with undergoing autism genetic testing. Psychology and Cognitive Science, 1, 29–38.
Xu, L., Mitchell, L. C., Richman, A. R., & Clawson, C. (2016a). What do parents think about chromosomal microarray testing? A qualitative report from parents of children with autism spectrum disorders. Autism Research and Treatment, 2016, 1–9. https://doi.org/10.1155/2016/6852539.
Xu, L., Sun, L., Mitchell, L. C., & Floyd, E. A. (2016b). Chromosomal microarray genetic testing—a qualitative investigation among parents of children with autism spectrum disorders in rural North Carolina. Journal of Clinical & Medical Genomics. https://doi.org/10.4172/2472-128X.1000143.
Žilina, O., Teek, R., Tammur, P., Kuuse, K., et al. (2014). Chromosomal microarray analysis as a first-tier clinical diagnostic test: Estonian experience. Molecular Genetics & Genomic Medicine, 2(2), 166–175.
Acknowledgements
We want to thank the parents of the children with ASD who participated in our study as well as the autism parents’ support groups/organizations, and public school teachers for their support for this study.
Funding
This research was supported by a grant from the Simons Foundation (SFARI [award no. 369023], [XL]).
Author information
Authors and Affiliations
Contributions
LX: designed and executed the study, analyzed the data, and wrote the paper. LCM: collaborated with the design, execution, and writing of the study. ARR: collaborated with the design and execution of the study, writing, extensive critique, and final editing of the manuscript. HBL: analyzed the data, wrote part of the results, and edited the final manuscript. YHJ: collaborated with the design and editing of the final manuscript the study. ALD and AEF: collaborated with the design and editing of the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethics Statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board at East Carolina University (no. 15-001803).
Informed Consent
Informed consent was obtained from all individual participants included in this study.
Rights and permissions
About this article
Cite this article
Xu, L., Mitchell, L.C., Richman, A.R. et al. Parental Knowledge and Perceptions of Pediatric Genomic Testing for Autism Spectrum Disorders in Rural Settings. Adv Neurodev Disord 2, 402–411 (2018). https://doi.org/10.1007/s41252-018-0069-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41252-018-0069-1